Loading…
Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy
Mesenchymal stem cells (MSCs) have attracted great interest in the field of kidney transplantation due to their immunomodulatory and reparative properties. In registered clinical trials, MSCs have been used before, at the time of, or early after transplantation and have been reported to be well-tole...
Saved in:
Published in: | Frontiers in medicine 2021-07, Vol.8 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c406t-168e0b15499177737dbd31f4cec40fd722ce6bca8d56e0a1df6b8933baf4900d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c406t-168e0b15499177737dbd31f4cec40fd722ce6bca8d56e0a1df6b8933baf4900d3 |
container_end_page | |
container_issue | |
container_start_page | |
container_title | Frontiers in medicine |
container_volume | 8 |
creator | Večerić-Haler, Željka Kojc, Nika Sever, Matjaž Zver, Samo Švajger, Urban Poženel, Primož Hartman, Katrina Urdih, Tereza Mlinšek, Gregor Oblak, Manca Aleš Rigler, Andreja Ihan, Alojz Buturović Ponikvar, Jadranka Halloran, Philip P. Arnol, Miha |
description | Mesenchymal stem cells (MSCs) have attracted great interest in the field of kidney transplantation due to their immunomodulatory and reparative properties. In registered clinical trials, MSCs have been used before, at the time of, or early after transplantation and have been reported to be well-tolerated with no serious safety concerns. No results are available on the use of MSCs in the late post-transplant period. Here, we present a case report of a severe systemic complication mimicking capillary leak syndrome with ultimate kidney transplant failure after autologous transplantation of MSCs used as rescue treatment of late antibody-mediated kidney allograft rejection. |
doi_str_mv | 10.3389/fmed.2021.708744 |
format | article |
fullrecord | <record><control><sourceid>pubmedcentral_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a6adb45b32564318ba1507aca3e608c6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_a6adb45b32564318ba1507aca3e608c6</doaj_id><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8334176</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-168e0b15499177737dbd31f4cec40fd722ce6bca8d56e0a1df6b8933baf4900d3</originalsourceid><addsrcrecordid>eNpVkcFu1DAQhiMEolXpnaNfYBc7dmyHA1IVsVB1ERJdBDdrbE92U5w4srNFeXuyXYToaUbzaz5p5iuKt4yuOdf1u7ZHvy5pydaKaiXEi-KyLGu50pX--fK__qK4zvmBUsp4WQnGXxcXXHCpWa0vi8cGMpJvOMY0vScNjF0IkGayRfhF7ufBp9gj-dFNB3LX-QFnsksw5DHAMJENdOGYkGxiCPF3N-zJzXGKIe7jMZMvmHFwh7mHQO4n7EmDIZDdAROM85viVQsh4_XfelV833zcNZ9X26-fbpub7coJKqcVkxqpZZWoa6aU4spbz1krHC5561VZOpTWgfaVRArMt9LqmnMLragp9fyquD1zfYQHM6auX44zETrzNIhpbyBNnQtoQIK3orLLk6TgTFtgFVXggKOk2smF9eHMGo92eb3DYUoQnkGfJ0N3MPv4aDTngqkTgJ4BLsWcE7b_dhk1J6XmpNSclJqzUv4HmoqWcg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy</title><source>PubMed Central</source><creator>Večerić-Haler, Željka ; Kojc, Nika ; Sever, Matjaž ; Zver, Samo ; Švajger, Urban ; Poženel, Primož ; Hartman, Katrina ; Urdih, Tereza ; Mlinšek, Gregor ; Oblak, Manca ; Aleš Rigler, Andreja ; Ihan, Alojz ; Buturović Ponikvar, Jadranka ; Halloran, Philip P. ; Arnol, Miha</creator><creatorcontrib>Večerić-Haler, Željka ; Kojc, Nika ; Sever, Matjaž ; Zver, Samo ; Švajger, Urban ; Poženel, Primož ; Hartman, Katrina ; Urdih, Tereza ; Mlinšek, Gregor ; Oblak, Manca ; Aleš Rigler, Andreja ; Ihan, Alojz ; Buturović Ponikvar, Jadranka ; Halloran, Philip P. ; Arnol, Miha</creatorcontrib><description>Mesenchymal stem cells (MSCs) have attracted great interest in the field of kidney transplantation due to their immunomodulatory and reparative properties. In registered clinical trials, MSCs have been used before, at the time of, or early after transplantation and have been reported to be well-tolerated with no serious safety concerns. No results are available on the use of MSCs in the late post-transplant period. Here, we present a case report of a severe systemic complication mimicking capillary leak syndrome with ultimate kidney transplant failure after autologous transplantation of MSCs used as rescue treatment of late antibody-mediated kidney allograft rejection.</description><identifier>ISSN: 2296-858X</identifier><identifier>EISSN: 2296-858X</identifier><identifier>DOI: 10.3389/fmed.2021.708744</identifier><identifier>PMID: 34368198</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>autologous stem cell ; kidney graft ; kidney graft failure ; kidney transplant ; Medicine ; mesenchymal stem cell ; stem cell transplant</subject><ispartof>Frontiers in medicine, 2021-07, Vol.8</ispartof><rights>Copyright © 2021 Večerić-Haler, Kojc, Sever, Zver, Švajger, Poženel, Hartman, Urdih, Mlinšek, Oblak, Aleš Rigler, Ihan, Buturović Ponikvar, Halloran and Arnol. 2021 Večerić-Haler, Kojc, Sever, Zver, Švajger, Poženel, Hartman, Urdih, Mlinšek, Oblak, Aleš Rigler, Ihan, Buturović Ponikvar, Halloran and Arnol</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-168e0b15499177737dbd31f4cec40fd722ce6bca8d56e0a1df6b8933baf4900d3</citedby><cites>FETCH-LOGICAL-c406t-168e0b15499177737dbd31f4cec40fd722ce6bca8d56e0a1df6b8933baf4900d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334176/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334176/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids></links><search><creatorcontrib>Večerić-Haler, Željka</creatorcontrib><creatorcontrib>Kojc, Nika</creatorcontrib><creatorcontrib>Sever, Matjaž</creatorcontrib><creatorcontrib>Zver, Samo</creatorcontrib><creatorcontrib>Švajger, Urban</creatorcontrib><creatorcontrib>Poženel, Primož</creatorcontrib><creatorcontrib>Hartman, Katrina</creatorcontrib><creatorcontrib>Urdih, Tereza</creatorcontrib><creatorcontrib>Mlinšek, Gregor</creatorcontrib><creatorcontrib>Oblak, Manca</creatorcontrib><creatorcontrib>Aleš Rigler, Andreja</creatorcontrib><creatorcontrib>Ihan, Alojz</creatorcontrib><creatorcontrib>Buturović Ponikvar, Jadranka</creatorcontrib><creatorcontrib>Halloran, Philip P.</creatorcontrib><creatorcontrib>Arnol, Miha</creatorcontrib><title>Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy</title><title>Frontiers in medicine</title><description>Mesenchymal stem cells (MSCs) have attracted great interest in the field of kidney transplantation due to their immunomodulatory and reparative properties. In registered clinical trials, MSCs have been used before, at the time of, or early after transplantation and have been reported to be well-tolerated with no serious safety concerns. No results are available on the use of MSCs in the late post-transplant period. Here, we present a case report of a severe systemic complication mimicking capillary leak syndrome with ultimate kidney transplant failure after autologous transplantation of MSCs used as rescue treatment of late antibody-mediated kidney allograft rejection.</description><subject>autologous stem cell</subject><subject>kidney graft</subject><subject>kidney graft failure</subject><subject>kidney transplant</subject><subject>Medicine</subject><subject>mesenchymal stem cell</subject><subject>stem cell transplant</subject><issn>2296-858X</issn><issn>2296-858X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkcFu1DAQhiMEolXpnaNfYBc7dmyHA1IVsVB1ERJdBDdrbE92U5w4srNFeXuyXYToaUbzaz5p5iuKt4yuOdf1u7ZHvy5pydaKaiXEi-KyLGu50pX--fK__qK4zvmBUsp4WQnGXxcXXHCpWa0vi8cGMpJvOMY0vScNjF0IkGayRfhF7ufBp9gj-dFNB3LX-QFnsksw5DHAMJENdOGYkGxiCPF3N-zJzXGKIe7jMZMvmHFwh7mHQO4n7EmDIZDdAROM85viVQsh4_XfelV833zcNZ9X26-fbpub7coJKqcVkxqpZZWoa6aU4spbz1krHC5561VZOpTWgfaVRArMt9LqmnMLragp9fyquD1zfYQHM6auX44zETrzNIhpbyBNnQtoQIK3orLLk6TgTFtgFVXggKOk2smF9eHMGo92eb3DYUoQnkGfJ0N3MPv4aDTngqkTgJ4BLsWcE7b_dhk1J6XmpNSclJqzUv4HmoqWcg</recordid><startdate>20210721</startdate><enddate>20210721</enddate><creator>Večerić-Haler, Željka</creator><creator>Kojc, Nika</creator><creator>Sever, Matjaž</creator><creator>Zver, Samo</creator><creator>Švajger, Urban</creator><creator>Poženel, Primož</creator><creator>Hartman, Katrina</creator><creator>Urdih, Tereza</creator><creator>Mlinšek, Gregor</creator><creator>Oblak, Manca</creator><creator>Aleš Rigler, Andreja</creator><creator>Ihan, Alojz</creator><creator>Buturović Ponikvar, Jadranka</creator><creator>Halloran, Philip P.</creator><creator>Arnol, Miha</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210721</creationdate><title>Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy</title><author>Večerić-Haler, Željka ; Kojc, Nika ; Sever, Matjaž ; Zver, Samo ; Švajger, Urban ; Poženel, Primož ; Hartman, Katrina ; Urdih, Tereza ; Mlinšek, Gregor ; Oblak, Manca ; Aleš Rigler, Andreja ; Ihan, Alojz ; Buturović Ponikvar, Jadranka ; Halloran, Philip P. ; Arnol, Miha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-168e0b15499177737dbd31f4cec40fd722ce6bca8d56e0a1df6b8933baf4900d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>autologous stem cell</topic><topic>kidney graft</topic><topic>kidney graft failure</topic><topic>kidney transplant</topic><topic>Medicine</topic><topic>mesenchymal stem cell</topic><topic>stem cell transplant</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Večerić-Haler, Željka</creatorcontrib><creatorcontrib>Kojc, Nika</creatorcontrib><creatorcontrib>Sever, Matjaž</creatorcontrib><creatorcontrib>Zver, Samo</creatorcontrib><creatorcontrib>Švajger, Urban</creatorcontrib><creatorcontrib>Poženel, Primož</creatorcontrib><creatorcontrib>Hartman, Katrina</creatorcontrib><creatorcontrib>Urdih, Tereza</creatorcontrib><creatorcontrib>Mlinšek, Gregor</creatorcontrib><creatorcontrib>Oblak, Manca</creatorcontrib><creatorcontrib>Aleš Rigler, Andreja</creatorcontrib><creatorcontrib>Ihan, Alojz</creatorcontrib><creatorcontrib>Buturović Ponikvar, Jadranka</creatorcontrib><creatorcontrib>Halloran, Philip P.</creatorcontrib><creatorcontrib>Arnol, Miha</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Večerić-Haler, Željka</au><au>Kojc, Nika</au><au>Sever, Matjaž</au><au>Zver, Samo</au><au>Švajger, Urban</au><au>Poženel, Primož</au><au>Hartman, Katrina</au><au>Urdih, Tereza</au><au>Mlinšek, Gregor</au><au>Oblak, Manca</au><au>Aleš Rigler, Andreja</au><au>Ihan, Alojz</au><au>Buturović Ponikvar, Jadranka</au><au>Halloran, Philip P.</au><au>Arnol, Miha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy</atitle><jtitle>Frontiers in medicine</jtitle><date>2021-07-21</date><risdate>2021</risdate><volume>8</volume><issn>2296-858X</issn><eissn>2296-858X</eissn><abstract>Mesenchymal stem cells (MSCs) have attracted great interest in the field of kidney transplantation due to their immunomodulatory and reparative properties. In registered clinical trials, MSCs have been used before, at the time of, or early after transplantation and have been reported to be well-tolerated with no serious safety concerns. No results are available on the use of MSCs in the late post-transplant period. Here, we present a case report of a severe systemic complication mimicking capillary leak syndrome with ultimate kidney transplant failure after autologous transplantation of MSCs used as rescue treatment of late antibody-mediated kidney allograft rejection.</abstract><pub>Frontiers Media S.A</pub><pmid>34368198</pmid><doi>10.3389/fmed.2021.708744</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2296-858X |
ispartof | Frontiers in medicine, 2021-07, Vol.8 |
issn | 2296-858X 2296-858X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_a6adb45b32564318ba1507aca3e608c6 |
source | PubMed Central |
subjects | autologous stem cell kidney graft kidney graft failure kidney transplant Medicine mesenchymal stem cell stem cell transplant |
title | Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T14%3A22%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case%20Report:%20Capillary%20Leak%20Syndrome%20With%20Kidney%20Transplant%20Failure%20Following%20Autologous%20Mesenchymal%20Stem%20Cell%20Therapy&rft.jtitle=Frontiers%20in%20medicine&rft.au=Ve%C4%8Deri%C4%87-Haler,%20%C5%BDeljka&rft.date=2021-07-21&rft.volume=8&rft.issn=2296-858X&rft.eissn=2296-858X&rft_id=info:doi/10.3389/fmed.2021.708744&rft_dat=%3Cpubmedcentral_doaj_%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8334176%3C/pubmedcentral_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c406t-168e0b15499177737dbd31f4cec40fd722ce6bca8d56e0a1df6b8933baf4900d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/34368198&rfr_iscdi=true |